Clobex Spray For Psoriasis Receives Approval
This article was originally published in The Pink Sheet Daily
Executive Summary
Galderma will market Dow Pharmaceutical Sciences' Clobex plaque psoriasis spray (clobetasol propionate 0.05%) following the super-high potency corticosteroid's Oct. 27 approval